# FDA recall D-1074-2019

> **Jubilant Cadista Pharmaceuticals, Inc.** · Class II · drug recall initiated 2019-03-29.

## Product

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD  21801; NDC 59746-284-90.

## Reason for recall

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-1074-2019
- **Recalling firm:** Jubilant Cadista Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-03-29
- **Report date:** 2019-04-10
- **Termination date:** 2019-09-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salisbury, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1074-2019

## Citation

> AI Analytics. FDA recall D-1074-2019. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-1074-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*